Theranostic nanoparticles for future personalized medicine
- 1 September 2014
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 190, 477-484
- https://doi.org/10.1016/j.jconrel.2014.04.027
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF-2013K1A1A2032346, 2012K1A1A2A01056095)
- Intramural Research Program (Theragnosis) of KIST
This publication has 68 references indexed in Scilit:
- Nanotheranostics for personalized medicineExpert Review of Molecular Diagnostics, 2013
- Theranostics in primary care: pharmacogenomics tests and beyondExpert Review of Molecular Diagnostics, 2012
- Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapyAdvanced Drug Delivery Reviews, 2012
- Personalized oncology: Recent advances and future challengesMetabolism, 2012
- Polymeric Lipid Assemblies as Novel Theranostic ToolsAccounts of Chemical Research, 2011
- Molecular Imaging with Theranostic NanoparticlesAccounts of Chemical Research, 2011
- Predictive biomarkers: a paradigm shift towards personalized cancer medicineNature Reviews Clinical Oncology, 2011
- In Vivo Targeted Delivery of Nanoparticles for TheranosisAccounts of Chemical Research, 2011
- Personalized Medicine: Marking a New Epoch in Cancer Patient ManagementMolecular Cancer Research, 2010
- Theranostic Nanomedicine for CancerNanomedicine, 2008